SCHEMBL8733887

SCHEMBL8733887

CC1(C)C=CC(C)(C)c2cc(C(=O)O)ccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 12/20 0.49
RARG P13631 11/20 0.49
RARA P10276 11/20 0.49
CYP26A1 O43174 5/20 0.49
CYP26B1 Q9NR63 1/20 0.49
RXRA P19793 9/20 0.49
RXRB P28702 6/20 0.49
RXRG P48443 4/20 0.49
CYP3A4 P08684 4/20 0.43
TSHR P16473 2/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
MEN1 O00255 1/20 0.43
CYP2C9 P11712 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
TP53 P04637 2/20 0.42
KDM4E B2RXH2 2/20 0.42
POLB P06746 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7225011 0.81 RARG (0.69) RARBRARGRARACYP26A1RXRA
SCHEMBL7225007 0.81 RARG (0.69) RARBRARGRARACYP26A1RXRA
SCHEMBL7225013 0.81 RARG (0.69) RARBRARGRARACYP26A1RXRA
SCHEMBL28133361 0.79 RARB (0.45) RARBRARGRARACYP26A1CYP26B1
SCHEMBL4317998 0.79 KMT2A (0.68) RARBRARGRARACYP26A1CYP26B1
SCHEMBL8771910 0.77 TDP2 (0.43) RARBRARGRARACYP26A1CYP26B1
SCHEMBL8462116 0.76 POLB (0.47) RARBRARGRARACYP26A1RXRA
SCHEMBL14782138 0.75 RXRA (0.70) RARBRARGRARACYP26A1CYP26B1
SCHEMBL1156918 0.74 RARB (0.47) RARBRARGRARACYP26A1CYP26B1
SCHEMBL29827631 0.74 RARB (0.81) RARBRARGRARACYP26A1CYP26B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869782-A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY Vision Pharmaceuticals L.P. (US) 1998-10-14 EP disclosed
WO-1997024116-A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY VISION PHARMACEUTICALS L.P. (US) 1997-07-10 WO disclosed